Esteban Barreto, PhD, is a Research Fellow in Medicine at Harvard Medical School and Director of Evaluation of Equity and Inclusion at Massachusetts General Hospital. For more than a decade at Mass General, Esteban has been involved in a variety of research areas such as health policy, program evaluation, patient experience and work culture. Esteban received a PhD in Industrial/Organizational Psychology from the University of Puerto Rico, Rio Piedras and a Bachelor of Arts from the University of Massachusetts, Boston.

Dr. Castle is an Infectious Diseases fellow at Massachusetts General Hospital. Her research interests focus on how tuberculosis and HIV affect the risk for noncommunicable diseases in resource limited settings. She is working with Drs. Siedner, Bassett, and Wong to study the relationship of tuberculosis and risk for diabetes in KwaZulu-Natal, South Africa.  She received her MD at Stony Brook University School of Medicine and completed an Internal Medicine residency at MGH.

Dr. Chiosi is an Infectious Diseases fellow at Massachusetts General Hospital. He is interested in the infectious complications of substance use disorder, including injection drug use. He is working with Dr. Ciaranello to develop a simulation model of infectious morbidity and mortality among people with opioid use disorder in order to project the clinical and economic impact of the opioid use epidemic in the US.

He earned his MD from the Icahn School of Medicine at Mount Sinai and completed his residency and chief residency in Internal Medicine-Pediatrics at Tulane University.

Yu-Han Chiu, MD, Sc.D., is currently a postdoctoral fellow at the Harvard T.H. Chan School of Public Health and the Mongan Institute at Massachusetts General Hospital. She received her MD from the National Taiwan University and her ScD from the Departments of Nutrition and Epidemiology at Harvard T.H. Chan School of Public Health. Her research focuses on the applications of causal inference methods to investigate the effect of exposure/treatment during pregnancy on maternal and child outcomes.

Dr. Curtis is a research fellow and infectious diseases physician at Massachusetts General Hospital and Brigham and Women’s Hospital. She will conduct research with Dr. Ciaranello and collaborators at Boston Medical Center evaluating the cost-effectiveness of Hepatitis C management strategies for pregnant women with opioid use disorder and their infants. Dr. Curtis completed her MS in Global Health Sciences at UCSF, MD at Tulane University School of Medicine, and residency in internal medicine at the University of Washington in Seattle. For her second year of her infectious diseases fellowship, she was the Brigham and Women’s Hospital HIV Fellow with focused training in the clinical care of patients living with HIV.   

Dr. Freret is a Maternal Fetal Medicine fellow at Massachusetts General Hospital. Her research focuses on interventions to increase the use of low-dose aspirin (LDA) for the prevention of preeclampsia, with a focus on techniques that prioritize equity. She earned her MD from Harvard Medical School and completed her residency in Obstetrics and Gynecology at the BWH/MGH Integrated Residency Program.

Dr. Brett Goshe is a postdoctoral clinical research fellow at Massachusetts General Hospital/Harvard Medical School. He received his Ph.D. from the University of Connecticut, specializing in health psychology and behavioral medicine. Dr. Goshe’s research and clinical practice focuses broadly on the mental health and treatment intervention development for vulnerable and underserved populations, particularly lesbian, gay, bisexual, and transgender (LGBT) individuals. The LGBT community, in contrast to the general population, experiences disproportionate rates of psychosocial problems, including poverty, substance abuse, cancer diagnosis, and most mental health conditions. These syndemic (i.e., overlapping epidemics) concerns present as increased potential for health-risk behaviors, such as sexual risk-taking, smoking, and substance abuse. Dr. Goshe seeks to develop a research program that evaluates these intersecting biopsychosocial processes and provides a scientific basis for addressing them clinically (e.g., adapting empirically-supported interventions).

Dr. Jarolimova is an Infectious Disease fellow at MGH and previously completed her internal medicine training in the MGH Global Medicine residency program. She received her medical degree from Harvard Medical School and MPH in Clinical Effectiveness from the Harvard School of Public Health. She is interested in care delivery for sexually transmitted infections and HIV in resource-limited settings. Her previous work focused on rural primary care delivery, HIV, and disparities in reproductive health, primarily in western Uganda. She is working with Dr. Bassett to study implementation of STI care and HIV prevention in South Africa.

Jenny Jia is a General Internal Medicine Fellow at Massachusetts General Hospital. Her research interests include interventions in the food environment and food supply to promote healthy diets and prevent chronic diseases, food insecurity, and health disparities, both domestically and globally. She earned her B.S. at Emory University and her M.D. at the Medical College of Georgia. She recently completed her residency training in Internal Medicine and Preventive Medicine at Boston Medical Center where she worked on research in food policy and disparities in diabetes outcomes.

Dr. Johnson is currently completing a fellowship in hematology and oncology at the Dana-Farber Cancer Institute / Mass General Brigham Program and serves as one of the chief fellows in hematology/oncology.  His research interests include analyzing patient-reported outcomes and designing interventions to improve the quality of life and care delivery of lymphoma and other hematologic malignancy patients and to mitigate the toxicity and burden of therapies.

Dr. Minsik Kim is a Research Fellow at Massachusetts General Hospital. He graduated with his BS, MS, and PhD degree at the Korea Advanced Institute of Science and Technology (KAIST). During his prior postdoctoral fellowship, he became fascinated by the microbiome when studying how microalgae treatment of wastewater reduces pathogenic bacteria through competitive microbe-microbe interactions. 

Daniel Lage is a fellow in hematology/oncology at the Massachusetts General Hospital and Dana-Farber Cancer Institute. He completed undergraduate studies at Harvard College, graduate study in policy and management at the University of Oxford, and received his MD from Harvard Medical School. He is interested in using patient-centered outcomes and health services research methods to improve the quality of care received by older patients with advanced cancer, and is particularly focused on improving transitions of care post-hospital discharge and studying post-acute care and hospice use.

Boram Lee is a Postdoctoral Research Fellow in the Health Policy Research Center and the Tobacco Research & Treatment Center at Massachusetts General Hospital. Her primary research interests include health disparities, evaluation of tobacco control policies, co-occurring substance use, and tobacco use among vulnerable populations including individuals with low socioeconomic status and those with mental illness. She earned her PhD in Health Behavior from the School of Public Health at Indiana University. She received her BPH and MA in Health Education and Management, and BA in Social Welfare from Ewha Womans University in South Korea.

Chun-Han Lo, MD, MPH, joined the Clinical and Translational Epidemiology Unit as a postdoctoral research fellow in 2020. He received his Doctor of Medicine at Chung Shan Medical University in Taichung, Taiwan and Master of Public Health in Quantitative Methods at the Harvard T.H. Chan School of Public Health in Boston, MA. His research focuses on nutritional epidemiology and pharmacoepidemiology related to digestive diseases, specifically colorectal cancer and inflammatory bowel disease.

Wenjie Ma joined the CTEU in 2017 with training and research experience in nutritional, genetic, and molecular epidemiology. Her research interests include understanding the etiology and developing intervention strategies for colorectal cancer, diverticulitis, and cardiovascular diseases and examining the role of gut microbiome in inflammation and diseases. Wenjie earned her ScD in Epidemiology from Harvard T.H. Chan School of Public Health. Before coming to the US, she graduated from Peking University in 2012 with a Bachelor’s degree in Medicine.

Dr. Amir Mohareb is an Infectious Diseases physician at Massachusetts General Hospital and Instructor at Harvard Medical School. His research uses epidemiology and simulation modeling to investigate HIV and hepatitis B management in resource-limited settings. He is mentored by Dr. Emily Hyle at the Medical Practice Evaluation Center. He also has clinical and research interests in refugees and other forcibly displaced populations.

Natalie McCormick is a post-doctoral research fellow in the Division of Rheumatology, Allergy, and Immunology's Clinical Epidemiology Program and in the Department of Medicine at Harvard Medical School, supervised by Dr. Hyon Choi. Natalie started at MGH in September 2018, shortly after completing her Ph.D. at The University of British Columbia (UBC) and Arthritis Research Canada. Her thesis examined the incremental direct medical costs of population-based cohorts of individuals with newly-diagnosed systemic autoimmune rheumatic diseases (i.e. systemic lupus erythematosus, systemic sclerosis, systemic vasculitides) and lost productivity costs, using provincial administrative health databases and survey data she collected from these individuals directly. Supported by a Fellowship Award from the Canadian Institutes of Health Research, Natalie is undertaking further research on the economic impact of rheumatic diseases while also developing new skills in causal inference analyses and related epidemiologic methods.

Arun Nagendra is a Postdoctoral Fellow in the Disparities Research Unit and the Center of Excellence in Psychosocial and Systemic Research. She received her undergraduate degree from Northwestern University and her master's and doctorate degrees in clinical psychology from the University of North Carolina at Chapel Hill. Along the way, she completed her predoctoral clinical internship at the Yale School of Medicine. She studies how various forms of racism, including assessment bias, contribute to disparities in Black Americans diagnosed with schizophrenia. Her long-term goal is to collaborate with community members to develop interventions that promote recovery and empowerment in Black Americans who experience psychosis. 

Dr. Nelson is a Postdoctoral Fellow in Oncology Population Sciences at the Harvard Cancer Center. Her research focuses on understanding quality of life impairments stemming from cancer diagnosis and treatment and adapting psychosocial interventions to alleviate physical and emotional side effects and improve quality of life. She is also interested in innovative methods for symptom assessment and intervention. Dr. Nelson’s clinical work focuses on providing evidence-based psychosocial care for cancer patients from diagnosis to survivorship. She provides CBT for symptom management for a variety of concerns, including emotional distress, fatigue, insomnia, and pain.

Dr. Newcomb is an Instructor of Medicine at Massachusetts General Hospital and cares for patients undergoing hematopoietic cell transplant (HCT). His research interests include analyzing patient-reported outcomes and designing interventions to improve the quality of life of patients undergoing HCT.

Dr. Perry is an Assistant Professor, Communication Sciences and Disorders, Program Director of Clinical Doctorate in Speech Language Pathology, and Director of the Swallowing and Communication Collaborative. The focus of her work is to elucidate the goals and concerns patients diagnosed with serious illnesses have about dysphagia care and develop and implement patient-centered dysphagia assessments and interventions that incorporate and align with patients’ goals of care and target improved quality of life for patients with serious illnesses whose dysphagia is unlikely to improve. Her work is well-aligned with the Health Decision Sciences Center which focuses on improving the quality of decisions made by patients and health care providers from diagnosis through treatment.

Dr. Pinkney is an Infectious Diseases fellow at Massachusetts General Hospital. She is interested in the cost effectiveness of interventions that address COVID-19 Vaccine Hesitancy, HIV prevention and HIV treatment in the US Black population including non-US born immigrants from Africa and the Caribbean. She is co-mentored by Drs. Emily Hyle and Bisola Ojikutu while conducting qualitative and simulation modeling studies in this area. She earned her medical degree and DM from the University of the West Indies in Jamaica. She completed her Internal Medicine residency at the University of South Carolina. 

Dr. Post is a postdoctoral research fellow at Massachusetts General Hospital. She has also worked as a Nurse Practitioner in breast oncology at Massachusetts General Hospital since 2007. In her tenure there she has worked both as a Clinical Research Nurse Practitioner and a Medical Oncology Nurse Practitioner. Recently, she completed her doctorate in philosophy from the William F. Connell School of Nursing at Boston College where her research focused on breast cancer survivorship. During her doctoral studies, she was awarded a pre-doctoral research fellowship at Boston College from 2015-2018. Dr. Post was also awarded the Doctoral Scholarship in Cancer Nursing from the American Cancer Society for 2017-2019. Dr. Post’s research interests center on improving the lives of cancer survivors and their families through developing person-centered survivorship interventions and programs. Dr. Post has presented her research findings on cancer survivorship at regional, national, and international scientific meetings. Dr. Post has published peer-reviewed articles and co-authored an online book chapter. She serves as an ad-hoc reviewer for peer-reviewed journals such as the Clinical Journal of Oncology Nursing, the Journal of Cancer Survivorship, the Journal of Women’s Health, and the International Journal of Nursing Knowledge.

Lacey B. Robinson, MD, is an Allergist/Immunologist at Massachusetts General Hospital, Instructor in Medicine at Harvard Medical School, and clinical research fellow. Her research focuses on early life risk-factors for the development of allergic disease with a special interest in the potential role of acid suppressant medications.

Abubaker Saeed (Elbur), Ph.D., is a Research Fellow at Massachusetts General Hospital. Abubaker received a Ph.D. in Pharmacy Practice from the University of Gezira, Sudan, and a Bachelor of Pharmacy from the University of Khartoum, Sudan. For more than two decades, Abubaker has been involved in a variety of research areas in pharmacy practice that include antibiotics use, adherence to medication and lifestyle recommendations for patients with chronic diseases, as well as other topics related to public health. Abubaker research interest is in the development and implementation of pharmacy-based interventions to reduce healthcare disparities.

Magdalena Sevilla is a postdoctoral researcher at Manning Lab. She is passionate about solving population health problems related to metabolic diseases, particularly type 2 diabetes and its interaction with obesity and environmental factors. She worked with “The Slim Initiative in Genomic Medicine for the Americas (SIGMA) T2D Consortium,” which aims to identify the genetic risk factors that contribute to the metabolic rate disparity between Mexicans and Caucasians. Her work has focused on providing important evidence to demonstrate the influence of Mexican-specific variants on treatment and physiological responses in high risk T2D subjects. She received training at The Broad Institute of MIT and Harvard in complex approaches to analyzing metabolomic patterns associated with an increased risk for type 2 diabetes. Moving forward, Magda’s broader research interest is in using mathematical models and complex biostatistics methods for the integration of genetic, metabolomic, and environmental characteristics, and in tailored nutritional interventions to prevent or treat type 2 diabetes in vulnerable populations.

Natalie Smith earned her PhD in Health Policy and Management and her MS in Biostatistics from UNC Chapel Hill. Her main research interest is to promote the implementation of evidence-informed policies to prevent cancer and chronic disease. To that end, she pursues research geared towards (1) using decision support methods, mainly simulation modeling, to assess the comparative health and economic effects of public health policies, and (2) improving how researchers disseminate findings from simulation modeling studies to policymakers.

Alejandro Szmulewicz, MD, MPH, graduated from Buenos Aires University in 2011 as a medical doctor, after which he served as a psychiatric resident for 4 years and chief resident for 1 year. He graduated from the Master Program in Quantitative Methods from the Harvard TH Chan School of Public Health in May 2017 and is now a PhD candidate at the same school. His interests include the application of causal inference methods to detect optimal treatment strategies for adults with mental health conditions.

Dr. Valentine is a Postdoctoral Research Fellow with the Health Decision Sciences Center in the General Medicine Division at Massachusetts General Hospital. She is joining Dr. Sepucha and team to support several research projects, including the PCORI-funded comparative effectiveness study of physician interventions to assist when making the decision about colorectal cancer screening for older adults. She is interested in shared decision making, risk communication, the validity of measurements of decision quality and patient preferences, and patient’s reactions to recommendations and guidelines. She holds a Bachelor of Science in Psychology from Missouri State University, a Master of Science in Experimental Psychology from Missouri State University, and a Doctorate of Philosophy in Quantitative Psychology from the University of Missouri.

Yiqing Wang is a research fellow in the Clinical and Translational Epidemiology Unit (CTEU). She received a BS in Biochemistry from the University of Virginia and a PhD in Nutrition Epidemiology from the University of North Carolina at Chapel Hill. Her current research interests include the roles of diet, genetics, metabolomics, and gut microbiome in the pathogenesis of colorectal cancer, inflammatory bowel disease, and cardiovascular diseases.

Kenny Westerman is a research fellow in the CTEU, interested in developing improved approaches to personalized nutrition using genomic and bioinformatic methods. He received his PhD in Biochemical and Molecular Nutrition from Tufts University, and is now a part of the Manning Laboratory, where his work involves the development of software for large-scale gene-environment interaction analysis and its application in uncovering novel gene-diet interactions. When not in the lab, he can often be found salsa dancing, playing the piano, or bargain hunting at Whole Foods.

Chio Yokose, MD, is a third-year rheumatology fellow at Massachusetts General Hospital. Her primary research mentor is Hyon K. Choi, MD, DrPH, also from the Division of Rheumatology, Allergy, and Immunology. Her research focuses on crystal arthropathies such as gout and pseudogout, with a particular focus on investigating the comorbidity patterns and burden associated with gout and the application of novel imaging techniques to better understand the association between gout and cardiovascular disease. 

Liao Zhang’s work at the Disparities Research Unit of Massachusetts General Hospital mainly focuses on the significance of cultural context of mental illnesses and the challenges of addressing ethnic diversity in mental health services. He aims to reach out to minority population that has known health disparities in the incidence of major mood disorders. To achieve this goal, he works closely with local Asian communities in Greater Boston areas. He goes out to the field and meets with racial/ethnic minorities at their communities and listens to their voices regarding mental health. Through in-person interviews, his research seeks to understand the social and cultural determinants of mental health.